Informations:
Erreur:
ID
17180
Description
Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00607932
Lien
https://clinicaltrials.gov/show/NCT00607932
Mots-clés
Versions (1)
- 30/08/2016 30/08/2016 -
Téléchargé le
30 août 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Prostate Cancer NCT00607932
Eligibility Prostate Cancer NCT00607932
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00607932
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Prostate cancer with psa recurrence after prostatectomy
Item
diagnosis of prostate cancer with psa recurrence after prostatectomy
boolean
C0600139 (UMLS CUI [1])
C2985506 (UMLS CUI [2,1])
C0033573 (UMLS CUI [2,2])
C2985506 (UMLS CUI [2,1])
C0033573 (UMLS CUI [2,2])
PSA recurrence
Item
psa recurrence is defined as two consecutively rising psa tests ≥ 8 weeks since the post-surgical nadir, with a minimal interval of 2 weeks between tests and at least 1 psa test > 0.4 ng/ml
boolean
C0201544 (UMLS CUI [1])
life expectancy
Item
life expectancy ≥ 9 months
boolean
C0023671 (UMLS CUI [1])
Compliance behavior
Item
no predictors of poor adherence (e.g., erratic life-style, mental incompetence)
boolean
C1321605 (UMLS CUI [1])
concurrent therapy
Item
prior concurrent therapy: see disease characteristics
boolean
C0009429 (UMLS CUI [1])
brassica vegetable consumption
Item
no other concurrent brassica vegetable consumption > 1 serving/day
boolean
C0453113 (UMLS CUI [1])
Indole-3-carbinol supplements
Item
no other concurrent indole-3-carbinol supplements
boolean
C0063491 (UMLS CUI [1])
no endocrine or radiation treatment
Item
no endocrine or radiation treatment within past 4 weeks
boolean
C0279025 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
other treatment
Item
no other scheduled treatment during study intervention
boolean
C0087111 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
prescription medications
Item
concurrent prescription medications during the trial allowed
boolean
C0304227 (UMLS CUI [1])
vitamin or herbal supplement use
Item
at least 2 weeks since prior and no concurrent vitamin or herbal supplement use
boolean
C0681579 (UMLS CUI [1])
C1504473 (UMLS CUI [2])
C1504473 (UMLS CUI [2])
patients refusing to stop non-study supplements will be asked to maintain constant use
Item
patients refusing to stop non-study supplements will be asked to maintain constant use
boolean
C0242295 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,2])